Market Research Logo

Pain Management Drugs Market - Global Forecast to 2026

Pain Management Drugs Market - Global Forecast to 2026

Pain management drugs are prescribed in serious to mild pain conditions such as back pain, neck pain, and pain from cancer. Pain management drugs market is highly lucrative due to low availability of alternative drug therapies for treatment of pain. Drug manufacturers are introducing effective generic version in various dosage forms, which is driving the market growth. Chronic pain is one of the highly prevalent pain disorders, which is primarily treated by these medications. The medical management of pain diseases is patient specific and is highly dependent on individual patients’ symptoms.
Market Dynamics
The global pain management drugs market is driven by factors such as absence of alternative therapies and high presence of generic drug manufacturers in the market. Increasing number of major drugs such as OxyContin, Opana ER, and Celebrex have lost patent protection due to which generic manufacturers have developed generic version with product variations fostering growth of the pain management drugs market. Continuous requirement of the medication coupled with easy availability is expected to boost the adoption of pain drugs over the forecast period. Proven effectiveness of these medications in improving medical outcomes and increasing prevalence of disorders such as cancer (leading to cancer pain) are fueling growth of the pain management drugs market. However, life threatening side effects associated with these medications, as indicated by the black box warning on the packaging, as well as lack of research and development by major players are expected to hinder growth of the pain management drugs market.
Key features of the study:

  • This report provides in-depth analysis of pain management drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018–2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global pain management drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Abbott Laboratories, Purdue Pharma L.P., GlaxoSmithKline Plc, Johnson & Johnson, and F. Hoffmann La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global pain management drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pain management drugs market
Detailed Segmentation:
  • Global Pain Management Drugs Market, by Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • Global Pain Management Drugs Market, by Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Pain Management Drugs Market, by Region:
  • North America
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Drug Class:
  • Opioids
  • NSAIDs
  • Anticonvulsants
  • Antidepressants
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Pfizer, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Sanofi S.A.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company
  • Abbott Laboratories
  • Purdue Pharma L.P.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • F. Hoffmann La Roche Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
PEST Analysis
PORTER’s Analysis
Regulatory Scenario
4. Global Pain Management Drugs Market, By Drug Class, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2017–2026
Segment Trends
Opioids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
NSAIDs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Muscle Relaxants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
5. Global Pain Management Drugs Market, By Distribution Channel, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, 2017 and 2026 (%)
Y-o-Y Growth Analysis, 2016–2026
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
6. Global Pain Management Drugs Market, By Regions, 2016–2026 (US$ Mn)
Introduction
Market Share Analysis, By Region, 2017 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of APAC
Latin America
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
Central Africa
South Africa
North Africa
Middle East
Market Size and Forecast, By Drug Class, 2016–2026 (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2016–2026 (US$ Mn)
Market Size and Forecast, By Country, 2016–2026 (US$ Mn)
GCC
Israel
Rest of Middle East
7. Competitive Landscape
Company Profiles
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Mylan N.V.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Eily, Lilly, and Company
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Abbott Laboratories
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Purdue Pharma L.P.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Johnson & Johnson
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
F. Hoffmann La Roche Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 55 figures on "Pain Management Drugs Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report